Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nuvastatic for Chemotherapy-Induced Fatigue in Metastatic TNBC
NCT07669467Phase 3Recruiting
- Sponsor
- Natureceuticals
- Start
- Oct 2025
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
A Phase 3 trial of Nuvastatic in cancer-related fatigue (CRF), sponsored by Natureceuticals. Started Oct 2025; status: recruiting.
02
Drugs
Nuvastatic
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on NCT07669467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07669467.